Preventive Treatment of Groin Pain in Football

February 3, 2023 updated by: Luca Puce, Universita degli Studi di Genova

Preventive Treatment of Groin Pain Syndrome in élite Young Football Player: a Pilot Study

Groin pain represents a common issue in football. Currently, there are no prevention protocols demonstrating real effectiveness. We aimed to investigate the possible positive effect of a prevention program for groin pain.Forty-two élite male athletes belonging to a youth academy of a professional football club were recruited in this prospective, randomized, controlled, single-blind, study.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Italy
      • Genova, Italy, 16122
        • Università degli Studi di Genova

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 18 years (ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • subjects between the ages of sixteen and eighteen, belonging to the youth sector of a professional club.

Exclusion Criteria:

  • Presence of pain or injuries at the level of the hip-hip region at the initial assessment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: control group
EXPERIMENTAL: preventive treatment group
Other: preventive treatment group
each athlete belonging to the preventive treatment group performed the protocol of preventive treatment 2 times a week, before or after the training session for five months

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength in the adductors
Time Frame: One day before the start of the physical protocol and one day after the end of the physical protocol
The strength was evaluated in Newton during maximal voluntary isometric contraction used a dynamometer (Activforce 2)
One day before the start of the physical protocol and one day after the end of the physical protocol

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain in the hip joint
Time Frame: One day before the start of the physical protocol and one day after the end of the physical protocol
The pain was rated using the Numeric Pain Rating Scale (NPRS) (0-10; 0 represents no pain and 10 represents maximum pain) during maximal voluntary isometric contraction (Copenhagen five-second squeeze test).
One day before the start of the physical protocol and one day after the end of the physical protocol
Groin pain
Time Frame: One day before the start of the physical protocol and one day after the end of the physical protocol
The pain was rated using the Numeric Pain Rating Scale (NPRS) (0-10; 0 represents no pain and 10 represents maximum pain) during maximal voluntary isometric contraction (Copenhagen five-second squeeze test).
One day before the start of the physical protocol and one day after the end of the physical protocol
Range of motion (ROM) of the hip joint
Time Frame: One day before the start of the physical protocol and one day after the end of the physical protocol
ROM was assessed using the distance (cm) from the head of the fibula to the edge of the bed (Bent Knee Fall Out Test)
One day before the start of the physical protocol and one day after the end of the physical protocol

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universita degli Studi di Genova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 10, 2022

Primary Completion (ACTUAL)

May 20, 2022

Study Completion (ACTUAL)

December 20, 2022

Study Registration Dates

First Submitted

January 24, 2023

First Submitted That Met QC Criteria

February 3, 2023

First Posted (ACTUAL)

February 6, 2023

Study Record Updates

Last Update Posted (ACTUAL)

February 6, 2023

Last Update Submitted That Met QC Criteria

February 3, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • GP-DINOGMI-23

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on preventive treatment group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Sri Lanka

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe